Bloom Energy Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Bloom Energy Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.02B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.47B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.33B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.20B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $972.18M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $794.25M | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $213.54M | Mar 31, 2020 |
| FY2019 | Sep 30, 2019 | $224.31M | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | $200.33M | Mar 31, 2020 |
| FY2019 | Mar 31, 2019 | $147.00M | Mar 31, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.00B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.44B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.27B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.14B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $906.86M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $731.22M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $724.79M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $575.12M | Feb 26, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $587.40M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $404.65M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $197.79M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $148.29M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $197.58M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $165.79M | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $24.95M | Mar 31, 2020 |
| FY2019 | Sep 30, 2019 | $42.73M | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | $28.35M | Mar 31, 2020 |
| FY2019 | Mar 31, 2019 | $1.56M | Mar 31, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($302.12M) | Feb 15, 2024 |
| FY2023 | Dec 31, 2022 | ($301.71M) | Feb 15, 2024 |
| FY2021 | Dec 31, 2021 | ($164.45M) | Feb 25, 2022 |
| FY2021 | Dec 31, 2020 | ($157.55M) | Feb 25, 2022 |
| FY2019 | Dec 31, 2019 | ($65.83M) | Mar 31, 2020 |
| FY2019 | Sep 30, 2019 | ($51.75M) | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | ($81.91M) | Mar 31, 2020 |
| FY2019 | Mar 31, 2019 | ($104.92M) | Mar 31, 2020 |
| FY2019 | Dec 31, 2018 | ($115.45M) | Mar 31, 2020 |
| FY2019 | Sep 30, 2018 | ($80.50M) | Mar 31, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $72.80M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $22.91M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | ($208.91M) | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | ($260.99M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($114.50M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | ($80.79M) | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | ($47.87M) | Mar 31, 2020 |
| FY2019 | Sep 30, 2019 | ($34.91M) | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | ($63.28M) | Mar 31, 2020 |
| FY2019 | Mar 31, 2019 | ($86.74M) | Mar 31, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $185.99M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $148.63M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $155.87M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $150.61M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $103.40M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $83.58M | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $22.15M | Mar 31, 2020 |
| FY2019 | Sep 30, 2019 | $23.39M | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | $29.77M | Mar 31, 2020 |
| FY2019 | Mar 31, 2019 | $28.86M | Mar 31, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $113.95M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $92.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | ($372.53M) | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | ($191.72M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($60.68M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | ($98.80M) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $163.77M | Feb 25, 2022 |
| FY2019 | Sep 30, 2019 | $141.49M | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | $103.62M | Mar 31, 2020 |
| FY2019 | Mar 31, 2019 | ($9.85M) | Mar 31, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.76M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $58.85M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $83.74M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $116.82M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $49.81M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $37.91M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $51.05M | Feb 25, 2022 |
| FY2019 | Sep 30, 2019 | $39.69M | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | $23.62M | Mar 31, 2020 |
| FY2019 | Mar 31, 2019 | $11.95M | Mar 31, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.40B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $2.66B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $2.41B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.95B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.73B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.45B | Feb 25, 2022 |
| FY2020 | Jan 1, 2020 | $1.35B | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $1.32B | Feb 26, 2021 |
| FY2019 | Sep 30, 2019 | $1.36B | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | $1.41B | Mar 31, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.60B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $2.07B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $1.89B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.57B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.52B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.31B | Feb 25, 2022 |
| FY2020 | Jan 1, 2020 | $1.52B | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $1.49B | Feb 26, 2021 |
| FY2019 | Sep 30, 2019 | $1.49B | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | $1.53B | Mar 31, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $768.64M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $562.47M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $502.08M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $340.78M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | ($44.33M) | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $78.82M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($259.59M) | Feb 26, 2021 |
| FY2019 | Sep 30, 2019 | ($232.81M) | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | ($224.90M) | Mar 31, 2020 |
| FY2019 | Mar 31, 2019 | ($194.86M) | Mar 31, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $1.96M | Feb 25, 2022 |
| FY2021 | Dec 31, 2020 | $0 | Feb 25, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.99B) | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | ($3.90B) | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | ($3.87B) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($3.56B) | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | ($3.26B) | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | ($3.10B) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($2.95B) | Feb 26, 2021 |
| FY2019 | Sep 30, 2019 | ($2.88B) | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | ($2.83B) | Mar 31, 2020 |
| FY2019 | Mar 31, 2019 | ($2.75B) | Mar 31, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.45B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $802.85M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $664.59M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $348.50M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $396.04M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $246.95M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $202.82M | Feb 26, 2021 |
| FY2019 | Sep 30, 2019 | $226.50M | Mar 31, 2020 |
| FY2019 | Jun 30, 2019 | $308.01M | Mar 31, 2020 |
| FY2019 | Mar 31, 2019 | $320.41M | Mar 31, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.62B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.13B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $846.63M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $411.58M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $526.73M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $390.90M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $636.81M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $741.28M | Mar 31, 2020 |
| FY2018 | Dec 31, 2017 | $941.34M | Mar 22, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | (2) | Feb 25, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | (2) | Feb 25, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 0 | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | 10.35M | Mar 22, 2019 |